Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
PD Controller: Design01:26

PD Controller: Design

546
In automotive engineering, car suspension systems often employ Proportional Derivative (PD) controllers to enhance performance. PD controllers are utilized to adjust the damping force in response to road conditions. A controller, acting as an amplifier with a constant gain, demonstrates proportional control, with output directly mirroring input.
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
546

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The influence of different raw material processing methods on the quality of mulberry fruit wine.

Food chemistry: X·2026
Same author

Corrigendum to "PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer" [Cancer Lett. 598 (2024) 217112].

Cancer letters·2026
Same author

Biofilm-Activated Enzymatic Biofuel Cell-Based Self-Powered Wound Dressing.

ACS nano·2026
Same author

Clinical Breakthrough in Targeted Protein Degradation: Reflections on the Approval of ARV-471.

Cancer innovation·2026
Same author

Trans-10, cis-12 conjugated linoleic acid modulates offspring hepatic lipid metabolism by activating AMPK pathway associated with altered gut microbiota.

Biochimica et biophysica acta. Molecular and cell biology of lipids·2026
Same author

Caspase Recruitment Domain 6 (CARD6) is the therapeutic target of dihydroartemisinin for lupus nephritis based on Proteolysis Targeting Chimera (PROTAC) technology.

British journal of pharmacology·2026
Same journal

Semisynthesis of Mycothiazole Analogs having Distinct Bioactivity.

ACS medicinal chemistry letters·2026
Same journal

Investigation on the Cytotoxicity of Hydroxycinnamic and Hydroxybenzoic Acid-Based Natural Antioxidant Conjugated Terpyridine Analogues toward Triple-Negative Breast Cancer.

ACS medicinal chemistry letters·2026
Same journal

Beyond Neddylation Inhibition: X‑ray Structures Reveal Carbonic Anhydrase Isoform Selectivity of Pevonedistat.

ACS medicinal chemistry letters·2026
Same journal

Structure-Guided Discovery of Selective Polo-Like Kinase 3 Inhibitors.

ACS medicinal chemistry letters·2026
Same journal

Controlling Neuroplasticity Across Scales: Constrained Serotonergic Agonists, Neuroplastogens, and Adaptive Neuromodulation.

ACS medicinal chemistry letters·2026
Same journal

Degradation and Detection: Integrating BCL6 Targeted Protein Degradation with Biomarker-Guided BET Inhibition in Cancer.

ACS medicinal chemistry letters·2026
See all related articles

Related Experiment Video

Updated: Dec 26, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.3K

PROTAC Technology: Opportunities and Challenges.

Hongying Gao1,2, Xiuyun Sun1,2, Yu Rao1

  • 1MOE Key Laboratory of Protein Sciences, School of Pharmaceutical Sciences, MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Tsinghua University, Beijing 100084, P.R. China.

ACS Medicinal Chemistry Letters
|March 19, 2020
PubMed
Summary
This summary is machine-generated.

Targeted protein degradation using Proteolysis-Targeting Chimeras (PROTACs) is a promising therapeutic strategy. Understanding the opportunities and challenges of PROTACs is crucial for developing new protein degradation drugs.

More Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.6K
qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping
07:00

qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping

Published on: May 25, 2015

17.8K

Related Experiment Videos

Last Updated: Dec 26, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.3K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.6K
qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping
07:00

qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping

Published on: May 25, 2015

17.8K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Proteolysis-Targeting Chimeras (PROTACs) represent a novel therapeutic modality.
  • This approach leverages targeted protein degradation, a mechanism gaining significant traction in drug development.
  • Major pharmaceutical and biotechnology companies are actively investing in PROTAC technology.

Purpose of the Study:

  • To provide a perspective on the emerging field of PROTACs.
  • To outline the potential opportunities and inherent challenges associated with PROTAC technology.
  • To guide future research and development in protein degradation drugs and tools.

Main Methods:

  • Review of current literature and industry trends in targeted protein degradation.
  • Analysis of the technological landscape of PROTACs.
  • Synthesis of expert opinions on the future of PROTACs.

Main Results:

  • PROTACs have opened new avenues for drug development, offering a distinct therapeutic strategy.
  • The technology presents significant opportunities for addressing previously undruggable targets.
  • Key challenges include optimizing delivery, managing off-target effects, and ensuring therapeutic efficacy.

Conclusions:

  • PROTAC-induced targeted protein degradation is a transformative approach in modern drug discovery.
  • Addressing the identified challenges will be critical for the successful clinical translation of PROTACs.
  • Continued research into PROTACs and degrader tools will accelerate the development of next-generation therapeutics.